{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:49:10Z","timestamp":1782251350216,"version":"3.54.5"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/mpa.0b013e318064678a","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T23:20:29Z","timestamp":1236208829000},"page":"256-261","source":"Crossref","is-referenced-by-count":45,"title":["Ethyl Pyruvate Improves Survival and Ameliorates Distant Organ Injury in Rats With Severe Acute Pancreatitis"],"prefix":"10.1097","volume":"35","author":[{"given":"Bao-Quan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Zhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210212","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/archsurg.1993.01420170122019","article-title":"A clinically based classification system for acute pancreatitis.","volume":"128","author":"Bradley","year":"1993","journal-title":"Arch Surg"},{"key":"R2-10-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0749-0704(18)30068-X","article-title":"Acute pancreatitis. Medical management.","volume":"11","author":"Forsmark","year":"1995","journal-title":"Crit Care Clin"},{"key":"R3-10-20210212","first-page":"538","article-title":"Current conservative treatment of acute pancreatitis: evidence from animal and human studies.","volume":"40","author":"Niederau","year":"1993","journal-title":"Hepatogastroenterology"},{"key":"R4-10-20210212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00365529209095976","article-title":"New perspectives on acute pancreatitis.","volume":"192","author":"Leach","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"R5-10-20210212","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.0007-1323.2001.02025.x","article-title":"Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis.","volume":"89","author":"Buter","year":"2002","journal-title":"Br J Surg"},{"key":"R6-10-20210212","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice.","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"R7-10-20210212","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous high-mobility group box 1.","volume":"101","author":"Yang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-10-20210212","first-page":"G1402","article-title":"Early NF-kappaB activation is associated with hormone-induced pancreatitis.","volume":"275","author":"Gukovsky","year":"1998","journal-title":"Am J Physiol"},{"key":"R9-10-20210212","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1072-7515(02)01222-X","article-title":"Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis.","volume":"195","author":"Ethridge","year":"2002","journal-title":"J Am Coll Surg"},{"key":"R10-10-20210212","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1073\/pnas.192222999","article-title":"Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.","volume":"99","author":"Ulloa","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-10-20210212","doi-asserted-by":"crossref","first-page":"G212","DOI":"10.1152\/ajpgi.00022.2002","article-title":"Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock.","volume":"283","author":"Yang","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R12-10-20210212","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1046\/j.1523-1755.2003.00268.x","article-title":"Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice.","volume":"64","author":"Miyaji","year":"2003","journal-title":"Kidney Int"},{"key":"R13-10-20210212","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00003246-200108000-00003","article-title":"Ringer's ethyl pyruvate solution ameliorates ischemia\/reperfusion-induced intestinal mucosal injury in rats.","volume":"29","author":"Sims","year":"2001","journal-title":"Crit Care Med"},{"key":"R14-10-20210212","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.surg.2005.04.006","article-title":"Ethyl pyruvate ameliorates ileus induced by bowel manipulation in mice.","volume":"138","author":"Harada","year":"2005","journal-title":"Surgery"},{"key":"R15-10-20210212","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/00365528009181493","article-title":"Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis.","volume":"15","author":"Aho","year":"1980","journal-title":"Scand J Gastroenterol"},{"key":"R16-10-20210212","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1797","article-title":"The vagus nerve and the nicotinic anti-inflammatory pathway.","volume":"4","author":"Ulloa","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"R17-10-20210212","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/art.10854","article-title":"High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis.","volume":"48","author":"Ulloa","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R18-10-20210212","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R19-10-20210212","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.shk.0000188710.04777.9e","article-title":"HMBG-1 as a therapeutic target for infectious and inflammatory disorders.","volume":"25","author":"Mantell","year":"2006","journal-title":"Shock"},{"key":"R20-10-20210212","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/nm1124","article-title":"Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"R21-10-20210212","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1749-6632.2003.tb06075.x","article-title":"Ethyl pyruvate protects against lethal systemic inflammation by preventing HMGB1 release.","volume":"987","author":"Ulloa","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R22-10-20210212","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jim.2004.04.019","article-title":"Recombinant HMGB1 with cytokine-stimulating activity.","volume":"289","author":"Li","year":"2004","journal-title":"J Immunol Methods"},{"key":"R23-10-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.qco.0000224816.96986.67","article-title":"The role of high mobility group box-1 protein in severe sepsis.","volume":"19","author":"Sunden-Cullberg","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"R24-10-20210212","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.4049\/jimmunol.165.6.2950","article-title":"HMG-1 as a mediator of acute lung inflammation.","volume":"165","author":"Abraham","year":"2000","journal-title":"J Immunol"},{"key":"R25-10-20210212","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"R26-10-20210212","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.176.1.12","article-title":"Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.","volume":"176","author":"Mitola","year":"2006","journal-title":"J Immunol"},{"key":"R27-10-20210212","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1083\/jcb.152.6.1197","article-title":"The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.","volume":"152","author":"Degryse","year":"2001","journal-title":"J Cell Biol"},{"key":"R28-10-20210212","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nm0204-124","article-title":"Lipid unites disparate syndromes of sepsis.","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"R29-10-20210212","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm0503-517","article-title":"Novel strategies for the treatment of sepsis.","volume":"9","author":"Riedemann","year":"2003","journal-title":"Nat Med"},{"key":"R30-10-20210212","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/gast.2002.35391","article-title":"HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice.","volume":"123","author":"Sappington","year":"2002","journal-title":"Gastroenterology"},{"key":"R31-10-20210212","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00003246-200301001-00008","article-title":"Ethyl pyruvate: a novel anti-inflammatory agent.","volume":"31","author":"Fink","year":"2003","journal-title":"Crit Care Med"},{"key":"R32-10-20210212","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/01.CCM.0000130835.65462.06","article-title":"Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis.","volume":"32","author":"Yang","year":"2004","journal-title":"Crit Care Med"},{"key":"R33-10-20210212","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00024382-200212000-00004","article-title":"Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite\/nitrate concentrations in a rat model of lipopolysaccharide-induced shock.","volume":"18","author":"Venkataraman","year":"2002","journal-title":"Shock"},{"key":"R34-10-20210212","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1124\/jpet.102.043182","article-title":"Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated Caco-2 enterocytic monolayers.","volume":"304","author":"Sappington","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R35-10-20210212","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1124\/jpet.103.056622","article-title":"Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells.","volume":"308","author":"Song","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R36-10-20210212","doi-asserted-by":"crossref","first-page":"L259","DOI":"10.1152\/ajplung.00187.2003","article-title":"Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice.","volume":"286","author":"Han","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R37-10-20210212","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/jpet.104.079707","article-title":"Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65.","volume":"312","author":"Han","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R38-10-20210212","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7839144","article-title":"Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.","volume":"267","author":"Derijard","year":"1995","journal-title":"Science"},{"key":"R39-10-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/jir.1997.17.295","article-title":"Two forms of NF-kappa B1 (p105\/p50) in murine macrophages: differential regulation by lipopolysaccharide, interleukin-2, and interferon-gamma.","volume":"17","author":"Brown","year":"1997","journal-title":"J Interferon Cytokine Res"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006676-200710000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:50:39Z","timestamp":1618037439000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-200710000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e318064678a","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}